TwinBeech Capital’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Other funds holding FATE
TwinBeech Capital's FATE Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Fate Therapeutics (FATE) in Q3 2026: 22,980 shares worth $54.5K. The stake represents 0.01% of the portfolio and ranks #377 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in FATE as recently as Q4 2022.
TwinBeech Capital first reported a position in FATE in Q1 2021 and has held it in 7 quarters since. The position peaked at $4.78M in Q3 2022. 142 funds tracked by Wall St. Rank hold FATE as of Q3 2026.
- TwinBeech Capital held 22,980 shares of Fate Therapeutics worth $54.5K as of Q3 2026.
- Fate Therapeutics was a new TwinBeech Capital position in Q3 2026.
- Fate Therapeutics made up 0.01% of TwinBeech Capital's portfolio in Q3 2026, its #377 holding.
- TwinBeech Capital first reported a position in Fate Therapeutics in Q1 2021 and has held it in 7 quarters since.
- TwinBeech Capital's Fate Therapeutics position peaked at $4.78M in Q3 2022.
- 142 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.